Compare Bath & Body Works Inc (BBWI) vs JPMorgan Chase & Co (JPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bath & Body Works Inc vs JPMorgan Chase & Co — how do they compare? Bath & Body Works Inc trades at $19.4 (market cap $4.04B), while JPMorgan Chase & Co trades at $343.82 (market cap $911.47B). The key difference: JPMorgan Chase & Co is far larger — about 225.6× Bath & Body Works Inc's market cap, and Bath & Body Works Inc pays the higher dividend (3.99%). Which is the better fit depends on your goals.
| BBWI | JPM | |
|---|---|---|
Market Cap | $4.04B | $911.47B |
Sector | Consumer Cyclical | Financials |
52-Week High | $33.11 | $342.89 |
52-Week Low | $14.85 | $282.84 |
Enterprise Value | $7.93B | — |
Dividend Yield | 3.99% | 1.75% |
Volume | — | 10,479,943 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BBWI trades at $20.42, up 0.44% today, with a bearish technical signal but attractive valuation metrics including a P/E of 5.8 and P/S of 0.58. Recent earnings show mixed quarterly beats, with Q1 2026 exceeding expectations. The company maintains solid profitability with a 10.03% net income margin and positive cash flow trends projected for 2026. Strategic initiatives include a new Ulta Beauty partnership and international expansion to drive growth amid declining revenue trends.
Outlook: BBWI presents a value opportunity with deep valuation discounts and operational strengths, though persistent revenue declines and high debt pose risks. Analyst consensus is cautiously optimistic with a $22 price target, suggesting modest upside potential if turnaround efforts gain traction against competitive and macroeconomic headwinds.
JPMorgan Chase (JPM) trades at $334.53, down 0.58% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q1 and Q2 2026 earnings beats, with Q1 EPS of $5.94 versus $5.47 expected and Q2 EPS of $7.7 versus $5.59 expected, though Q4 2025 missed expectations. Revenue grew to $181.85B in 2025, with a net income margin of 31.61% and ROE of 17.03%. Analyst consensus is a Moderate Buy with a $369.67 price target, and recent news highlights CEO Jamie Dimon's economic warnings and upcoming bank earnings focus.
JPMorgan's outlook remains positive driven by earnings momentum and solid profitability, but risks include geopolitical tensions, cybersecurity threats from AI, and macroeconomic volatility cited by management. The stock offers potential upside to the consensus target, supported by institutional buying interest, though investors should weigh elevated debt levels and interest rate sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bath & Body Works Inc
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.
Read more on BBWI →About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →
